Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials

Journal of Clinical Epidemiology
Isabelle BoutronPhilippe Ravaud

Abstract

To compare the feasibility of blinding and the perceived risk of unblinding in trials evaluating pharmacologic (PT) and nonpharmacologic treatments (NPT) of hip or knee osteoarthritis. Two independent reviewers assessed the feasibility of blinding patients, care providers, and outcome assessors, the perceived risk of unblinding, and whether blinding was reported in 110 reports of randomized controlled trials (RCTs) evaluating PT and NPT in patients with hip or knee osteoarthritis. Blinding was considered to be possible less often in NPT trials than in PT trials for patients (42 vs. 96%; P <.001), care providers (12 vs. 96%; P <.001), and outcome assessors (34 vs. 98%; P <.001). When blinding was judged feasible, the perceived risk of unblinding was more often considered moderate or important in NPT than PT trials for patients (35 vs. 14%, P=.02) and outcome assessors (44 vs. 10%, P=.0004). When blinding was judged feasible, it was reported less often in NPT reports than in PT reports for patients (46 vs. 98%, P <.001), care providers (43 vs. 83%, P=.03), and outcome assessors (72 vs. 98%, P=.0006). Blinding appears to be more difficult to achieve and unblinding may occur more often in NPT than PT trials.

References

Nov 11, 1995·BMJ : British Medical Journal·I Russell
Feb 1, 1995·JAMA : the Journal of the American Medical Association·K F SchulzD G Altman
Jul 13, 1994·JAMA : the Journal of the American Medical Association·A C JusticeS N Goodman
May 1, 1996·Surgery·R S McLeodA l Lossing
Jul 24, 1998·JAMA : the Journal of the American Medical Association·S van RooyenN Black
Aug 26, 1998·Lancet·K Streitberger, J Kleinhenz
Aug 16, 2000·Journal of Clinical Epidemiology·T J KaptchukW B Stason
Aug 19, 2000·BMJ : British Medical Journal·S J Day, D G Altman
Apr 17, 2001·Annals of Internal Medicine·D G AltmanUNKNOWN CONSORT GROUP (Consolidated Standards of Reporting Trials)
Apr 20, 2001·JAMA : the Journal of the American Medical Association·P J DevereauxG H Guyatt
May 30, 2001·Journal of Clinical Epidemiology·T J Kaptchuk
Feb 6, 2002·Annals of Internal Medicine·Kenneth F SchulzDouglas G Altman
Mar 7, 2002·Lancet·Kenneth F Schulz, David A Grimes
Jun 1, 2002·JAMA : the Journal of the American Medical Association·Kirby P LeeLisa A Bero
Jun 18, 2002·BMJ : British Medical Journal·Peter McCullochDamian Griffin
Jul 12, 2002·The New England Journal of Medicine·J Bruce MoseleyNelda P Wray
Sep 7, 2002·JAMA : the Journal of the American Medical Association·Annette A M GerritsenLex M Bouter
Oct 18, 2002·Journal of Clinical Epidemiology·Victor M MontoriGordon H Guyatt
Mar 26, 2003·Journal of Clinical Epidemiology·Scott D Halpern
May 8, 2004·BMJ : British Medical Journal·David L Sackett
Mar 4, 2014·The Journal of Rheumatology·Maarten BoersPeter Tugwell

❮ Previous
Next ❯

Citations

Aug 26, 2006·Nature Clinical Practice. Rheumatology·Philippe Ravaud, Isabelle Boutron
Dec 4, 2010·Nursing Research·Denise F PolitRuth Griffin
Jun 5, 2010·BMJ : British Medical Journal·Fati NourhashemiUNKNOWN PLASA Group
Jan 21, 2009·BMC Musculoskeletal Disorders·Helen P FrenchGeraldine M McCarthy
Jan 21, 2011·Chiropractic & Manual Therapies·Howard VernonChristine Reinhart
Feb 22, 2007·PLoS Medicine·Isabelle BoutronPhilippe Ravaud
Jul 21, 2012·Journal of Strength and Conditioning Research·Anne M JensenMichael W Hall
Sep 3, 2008·The Journal of Bone and Joint Surgery. American Volume·Luis A CorralesTheodore Miclau
May 9, 2009·The Journal of Bone and Joint Surgery. American Volume·Rudolf W PoolmanHenrica C W de Vet
Feb 23, 2013·International Journal of Therapeutic Massage & Bodywork·Antony J Porcino
Apr 1, 2008·Indian Journal of Orthopaedics·Harman ChaudhryMohit Bhandari
Nov 16, 2013·Langenbeck's Archives of Surgery·Rhiannon C MacefieldJane M Blazeby
Mar 29, 2014·Journal of Medical Internet Research·Sylvia van BeugenAndrea Wm Evers
Apr 19, 2013·Disability and Rehabilitation·Davy VancampfortMichel Probst
Oct 23, 2012·Archives of Physical Medicine and Rehabilitation·Helen P FrenchGeraldine M McCarthy
Mar 4, 2011·International Journal of Nursing Studies·Denise F Polit
Sep 1, 2009·Journal of Clinical Epidemiology·Jasvinder A SinghMohit Bhandari
Jan 13, 2009·Journal of Clinical Epidemiology·Agnes DechartresPhilippe Ravaud
Jun 15, 2007·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Paul L P BrandAnthony E J Dubois
Feb 21, 2006·Journal of Pain and Symptom Management·Emma ReamCaroline Alexander-Dann
Sep 10, 2014·Arthritis Care & Research·David J Hunter
Jan 15, 2011·Osteoarthritis and Cartilage·D J HunterK Bennell
Jun 11, 2016·Joint, Bone, Spine : Revue Du Rhumatisme·Romain ForestierAlain Francon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.